{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:14:14Z","timestamp":1793229254205,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00213-011-2397-y","type":"journal-article","created":{"date-parts":[[2011,7,11]],"date-time":"2011-07-11T05:18:17Z","timestamp":1310361497000},"page":"783-794","source":"Crossref","is-referenced-by-count":62,"title":["Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat"],"prefix":"10.1007","volume":"219","author":[{"given":"Goran","family":"Jassim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silje","family":"Skrede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege","family":"Wergedal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audun O.","family":"Vik-Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niclas","family":"Lunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Di\u00e9guez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vidal-Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf K.","family":"Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidar M.","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Fern\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,12]]},"reference":[{"key":"2397_CR1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/mp.2010.33","volume":"16","author":"VL Albaugh","year":"2011","unstructured":"Albaugh VL, Judson JG, She P, Lang CH, Maresca KP, Joyal JL, Lynch CJ (2011) Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis. Mol Psychiatry 16:569\u2013581","journal-title":"Mol Psychiatry"},{"key":"2397_CR2","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","volume":"156","author":"DB Allison","year":"1999","unstructured":"Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiat 156:1686\u20131696","journal-title":"Am J Psychiat"},{"key":"2397_CR3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2008.06.105","volume":"592","author":"MB Assie","year":"2008","unstructured":"Assie MB, Carilla-Durand E, Bardin L, Maraval M, Aliaga M, Malfetes N, Barbara M, Newman-Tancredi A (2008) The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063. Eur J Pharmacol 592:160\u2013166","journal-title":"Eur J Pharmacol"},{"key":"2397_CR4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.physbeh.2007.04.002","volume":"91","author":"TJ Bartness","year":"2007","unstructured":"Bartness TJ, Song CK (2007) Brain-adipose tissue neural crosstalk. Physiol Behav 91:343\u2013351","journal-title":"Physiol Behav"},{"key":"2397_CR5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/JCP.0b013e318166c4f7","volume":"28","author":"AB Birkenaes","year":"2008","unstructured":"Birkenaes AB, Birkeland KI, Engh JA, Faerden A, Jonsdottir H, Ringen PA, Friis S, Opjordsmoen S, Andreassen OA (2008) Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions. J Clin Psychopharmacol 28:132\u2013137","journal-title":"J Clin Psychopharmacol"},{"key":"2397_CR6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911\u2013917","journal-title":"Can J Biochem Physiol"},{"key":"2397_CR7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.pnpbp.2010.04.024","volume":"34","author":"HN Boyda","year":"2010","unstructured":"Boyda HN, Tse L, Procyshyn RM, Wong D, Wu TK, Pang CC, Barr AM (2010) A parametric study of the acute effects of antipsychotic drugs on glucose sensitivity in an animal model. Prog Neuropsychopharmacol Biol Psychiatry 34:945\u2013954","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2397_CR8","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1210\/jc.2004-0930","volume":"90","author":"JE Caminos","year":"2005","unstructured":"Caminos JE, Nogueiras R, Gallego R, Bravo S, Tovar S, Garcia-Caballero T, Casanueva FF, Dieguez C (2005) Expression and regulation of adiponectin and receptor in human and rat placenta. J Clin Endocrinol Metab 90:4276\u20134286","journal-title":"J Clin Endocrinol Metab"},{"key":"2397_CR9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.schres.2008.12.012","volume":"108","author":"AF Chintoh","year":"2009","unstructured":"Chintoh AF, Mann SW, Lam L, Giacca A, Fletcher P, Nobrega J, Remington G (2009) Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model. Schizophr Res 108:127\u2013133","journal-title":"Schizophr Res"},{"key":"2397_CR10","doi-asserted-by":"crossref","first-page":"17517","DOI":"10.1074\/jbc.M702228200","volume":"282","author":"X Deng","year":"2007","unstructured":"Deng X, Yellaturu C, Cagen L, Wilcox HG, Park EA, Raghow R, Elam MB (2007) Expression of the rat sterol regulatory element-binding protein-1c gene in response to insulin is mediated by increased transactivating capacity of specificity protein 1 (Sp1). J Biol Chem 282:17517\u201317529","journal-title":"J Biol Chem"},{"key":"2397_CR11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1365-2826.2005.01367.x","volume":"17","author":"M Duclos","year":"2005","unstructured":"Duclos M, Bouchet M, Vettier A, Richard D (2005) Genetic differences in hypothalamic\u2013pituitary\u2013adrenal axis activity and food restriction-induced hyperactivity in three inbred strains of rats. J Neuroendocrinol 17:740\u2013752","journal-title":"J Neuroendocrinol"},{"key":"2397_CR12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.tpj.6500323","volume":"5","author":"J Ferno","year":"2005","unstructured":"Ferno J, Raeder MB, Vik-Mo AO, Skrede S, Glambek M, Tronstad KJ, Breilid H, Lovlie R, Berge RK, Stansberg C, Steen VM (2005) Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action? Pharmacogenomics J 5:298\u2013304","journal-title":"Pharmacogenomics J"},{"key":"2397_CR13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2202-7-69","volume":"7","author":"J Ferno","year":"2006","unstructured":"Ferno J, Skrede S, Vik-Mo AO, Havik B, Steen VM (2006) Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs. BMC Neurosci 7:69","journal-title":"BMC Neurosci"},{"key":"2397_CR14","doi-asserted-by":"crossref","first-page":"e20571","DOI":"10.1371\/journal.pone.0020571","volume":"6","author":"J Ferno","year":"2011","unstructured":"Ferno J, Varela S, Skrede S, V\u00e1zquez MJ, Nogueiras R, Di\u00e9guez C, Vidal-Puig A, Steen VM, L\u00f3pez M (2011) Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation. PLoS ONE 6:e20571","journal-title":"PLoS ONE"},{"key":"2397_CR15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00213-008-1370-x","volume":"203","author":"J Ferno","year":"2009","unstructured":"Ferno J, Vik-Mo AO, Jassim G, Havik B, Berge K, Skrede S, Gudbrandsen OA, Waage J, Lunder N, Mork S, Berge RK, Jorgensen HA, Steen VM (2009) Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver. Psychopharmacology (Berl) 203:73\u201384","journal-title":"Psychopharmacology (Berl)"},{"key":"2397_CR16","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00125-002-0873-y","volume":"45","author":"KN Frayn","year":"2002","unstructured":"Frayn KN (2002) Adipose tissue as a buffer for daily lipid flux. Diabetologia 45:1201\u20131210","journal-title":"Diabetologia"},{"key":"2397_CR17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1055\/s-2007-1009292","volume":"21","author":"H Hauner","year":"1989","unstructured":"Hauner H, Pfeiffer EF (1989) Regional differences in glucocorticoid action on rat adipose tissue metabolism. Horm Metab Res 21:581\u2013582","journal-title":"Horm Metab Res"},{"key":"2397_CR18","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1172\/JCI31021","volume":"117","author":"JY Kim","year":"2007","unstructured":"Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, Schraw T, Durand JL, Li H, Li G, Jelicks LA, Mehler MF, Hui DY, Deshaies Y, Shulman GI, Schwartz GJ, Scherer PE (2007a) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117:2621\u20132637","journal-title":"J Clin Invest"},{"key":"2397_CR19","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1073\/pnas.0611417104","volume":"104","author":"SF Kim","year":"2007","unstructured":"Kim SF, Huang AS, Snowman AM, Teuscher C, Snyder SH (2007b) Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase. PNAS 104:3456\u20133459","journal-title":"PNAS"},{"key":"2397_CR20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","volume":"28","author":"WK Kroeze","year":"2003","unstructured":"Kroeze WK, Hufeisen SJ, Popadak BA, Renock SM, Steinberg S, Ernsberger P, Jayathilake K, Meltzer HY, Roth BL (2003) H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 28:519\u2013526","journal-title":"Neuropsychopharmacology"},{"key":"2397_CR21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.phrs.2006.03.009","volume":"53","author":"D Langin","year":"2006","unstructured":"Langin D (2006) Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacological research: the official journal of the Italian Pharmacological Society 53:482\u2013491","journal-title":"Pharmacological research : the official journal of the Italian Pharmacological Society"},{"key":"2397_CR22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1104342","volume":"307","author":"MA Lazar","year":"2005","unstructured":"Lazar MA (2005) How obesity causes diabetes: not a tall tale. Science 307:373\u2013375","journal-title":"Science"},{"key":"2397_CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","volume":"373","author":"S Leucht","year":"2009","unstructured":"Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM (2009) Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373:31\u201341","journal-title":"Lancet"},{"key":"2397_CR24","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353:1209\u20131223","journal-title":"N Engl J Med"},{"key":"2397_CR25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.bbalip.2009.09.016","volume":"1801","author":"PB Martinez de Morentin","year":"2010","unstructured":"Martinez de Morentin PB, Varela L, Ferno J, Nogueiras R, Dieguez C, Lopez M (2010) Hypothalamic lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 1801:350\u2013361","journal-title":"Biochim Biophys Acta"},{"key":"2397_CR26","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.2337\/db10-0449","volume":"59","author":"PJ Martins","year":"2010","unstructured":"Martins PJ, Haas M, Obici S (2010) Central nervous system delivery of the antipsychotic olanzapine induces hepatic insulin resistance. Diabetes 59:2418\u20132425","journal-title":"Diabetes"},{"key":"2397_CR27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2169\/internalmedicine.47.0557","volume":"47","author":"T Nagamine","year":"2008","unstructured":"Nagamine T (2008) Olanzapine-induced elevation of serum triglyceride levels in a normal weight patient with schizophrenia. Intern Med 47:181\u2013182","journal-title":"Intern Med"},{"key":"2397_CR28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.mp.4002066","volume":"13","author":"HA Nasrallah","year":"2008","unstructured":"Nasrallah HA (2008) Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry 13:27\u201335","journal-title":"Mol Psychiatry"},{"issue":"Suppl 1","key":"2397_CR29","first-page":"1","volume":"19","author":"JW Newcomer","year":"2005","unstructured":"Newcomer JW (2005) Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 19(Suppl 1):1\u201393","journal-title":"CNS Drugs"},{"key":"2397_CR30","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1440-1681.2002.t01-1-03755.x","volume":"29","author":"M Ota","year":"2002","unstructured":"Ota M, Mori K, Nakashima A, Kaneko YS, Fujiwara K, Itoh M, Nagasaka A, Ota A (2002) Peripheral injection of risperidone, an atypical antipsychotic, alters the bodyweight gain of rats. Clin Exp Pharmacol Physiol 29:980\u2013989","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2397_CR31","first-page":"331","volume":"32","author":"RM Procyshyn","year":"2007","unstructured":"Procyshyn RM, Wasan KM, Thornton AE, Barr AM, Chen EY, Pomarol-Clotet E, Stip E, Williams R, Macewan GW, Birmingham CL, Honer WG (2007) Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment. J Psychiatry Neurosci 32:331\u2013338","journal-title":"J Psychiatry Neurosci"},{"key":"2397_CR32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11010-006-9160-4","volume":"289","author":"MB Raeder","year":"2006","unstructured":"Raeder MB, Ferno J, Vik-Mo AO, Steen VM (2006) SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects? Mol Cell Biochem 289:167\u2013173","journal-title":"Mol Cell Biochem"},{"key":"2397_CR33","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1194\/jlr.M600248-JLR200","volume":"47","author":"G Ranganathan","year":"2006","unstructured":"Ranganathan G, Unal R, Pokrovskaya I, Yao-Borengasser A, Phanavanh B, Lecka-Czernik B, Rasouli N, Kern PA (2006) The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment. J Lipid Res 47:2444\u20132450","journal-title":"J Lipid Res"},{"key":"2397_CR34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","volume":"125","author":"GP Reynolds","year":"2010","unstructured":"Reynolds GP, Kirk SL (2010) Metabolic side effects of antipsychotic drug treatment\u2014pharmacological mechanisms. Pharmacol Ther 125:169\u2013179","journal-title":"Pharmacol Ther"},{"key":"2397_CR35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.mco.0000172586.09762.55","volume":"8","author":"JA Romijn","year":"2005","unstructured":"Romijn JA, Fliers E (2005) Sympathetic and parasympathetic innervation of adipose tissue: metabolic implications. Curr Opin Clin Nutr Metab Care 8:440\u2013444","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2397_CR36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd1346","volume":"3","author":"BL Roth","year":"2004","unstructured":"Roth BL, Sheffler DJ, Kroeze WK (2004) Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nature reviews. Drug discovery 3:353\u2013359","journal-title":"Drug discovery"},{"key":"2397_CR37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2010.07.012","volume":"123","author":"C Rummel-Kluge","year":"2010","unstructured":"Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Lobos CA, Kissling W, Davis JM, Leucht S (2010) Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res 123:225\u2013233","journal-title":"Schizophr Res"},{"key":"2397_CR38","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/sj.npp.1301541","volume":"33","author":"J Sacher","year":"2008","unstructured":"Sacher J, Mossaheb N, Spindelegger C, Klein N, Geiss-Granadia T, Sauermann R, Lackner E, Joukhadar C, Muller M, Kasper S (2008) Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers. Neuropsychopharmacology 33:1633\u20131641","journal-title":"Neuropsychopharmacology"},{"key":"2397_CR39","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM199907223410406","volume":"341","author":"PR Shepherd","year":"1999","unstructured":"Shepherd PR, Kahn BB (1999) Glucose transporters and insulin action\u2014implications for insulin resistance and diabetes mellitus. N Engl J Med 341:248\u2013257","journal-title":"N Engl J Med"},{"key":"2397_CR40","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1742-4658.2008.06806.x","volume":"276","author":"H Shimano","year":"2009","unstructured":"Shimano H (2009) SREBPs: physiology and pathophysiology of the SREBP family. FEBS J 276:616\u2013621","journal-title":"FEBS J"},{"key":"2397_CR41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1097-2765(00)00009-5","volume":"6","author":"I Shimomura","year":"2000","unstructured":"Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL (2000) Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob\/ob mice. Mol Cell 6:77\u201386","journal-title":"Mol Cell"},{"key":"2397_CR42","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s00125-008-1152-3","volume":"51","author":"GC Smith","year":"2008","unstructured":"Smith GC, Chaussade C, Vickers M, Jensen J, Shepherd PR (2008) Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat. Diabetologia 51:2309\u20132317","journal-title":"Diabetologia"},{"key":"2397_CR43","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.schres.2009.07.011","volume":"115","author":"GC Smith","year":"2009","unstructured":"Smith GC, Vickers MH, Cognard E, Shepherd PR (2009) Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: implications for glucose metabolism and food choice behaviour. Schizophr Res 115:30\u201340","journal-title":"Schizophr Res"},{"key":"2397_CR44","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/oby.2008.468","volume":"17","author":"A Stefanidis","year":"2009","unstructured":"Stefanidis A, Verty AN, Allen AM, Owens NC, Cowley MA, Oldfield BJ (2009) The role of thermogenesis in antipsychotic drug-induced weight gain. Obesity 17:16\u201324","journal-title":"Obesity"},{"key":"2397_CR45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000100981","volume":"85","author":"G Tulipano","year":"2007","unstructured":"Tulipano G, Rizzetti C, Bianchi I, Fanzani A, Spano P, Cocchi D (2007) Clozapine-induced alteration of glucose homeostasis in the rat: the contribution of hypothalamic\u2013pituitary\u2013adrenal axis activation. Neuroendocrinology 85:61\u201370","journal-title":"Neuroendocrinology"},{"key":"2397_CR46","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1371\/journal.pbio.0060237","volume":"6","author":"S Virtue","year":"2008","unstructured":"Virtue S, Vidal-Puig A (2008) It's not how fat you are, it's what you do with it that counts. PLoS Biol 6:e237","journal-title":"PLoS Biol"},{"key":"2397_CR47","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbalip.2009.12.006","volume":"1801","author":"S Virtue","year":"2010","unstructured":"Virtue S, Vidal-Puig A (2010) Adipose tissue expandability, lipotoxicity and the metabolic syndrome\u2014an allostatic perspective. Biochim Biophys Acta 1801:338\u2013349","journal-title":"Biochim Biophys Acta"},{"key":"2397_CR48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/abio.1999.4085","volume":"270","author":"J Winer","year":"1999","unstructured":"Winer J, Jung CK, Shackel I, Williams PM (1999) Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270:41\u201349","journal-title":"Anal Biochem"},{"key":"2397_CR49","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.phrs.2007.05.007","volume":"56","author":"LH Yang","year":"2007","unstructured":"Yang LH, Chen TM, Yu ST, Chen YH (2007) Olanzapine induces SREBP-1-related adipogenesis in 3T3-L1 cells. Pharmacol Res 56:202\u2013208","journal-title":"Pharmacol Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00213-011-2397-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T02:17:53Z","timestamp":1686190673000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-011-2397-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,12]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["2397"],"URL":"https:\/\/doi.org\/10.1007\/s00213-011-2397-y","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,12]]}}}